Stock News

Temasek Holdings Private LTD Increased Its Alexion Pharmaceuticals (ALXN) Holding by $7.34 Million; Share Value Declined; As Kmg Chemicals (KMG) Valuation Rose, Trigran Investments Has Decreased by $9.19 Million Its Position

Temasek Holdings Private Ltd increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 3.61% based on its latest 2017Q3 regulatory filing with the SEC. Temasek Holdings Private Ltd bought 52,403 shares as the company’s stock declined 11.63% while stock markets rallied. The institutional investor held 1.51 million shares of the health care company at the end of 2017Q3, valued at $211.18 million, up from 1.45 million at the end of the previous reported quarter. Temasek Holdings Private Ltd who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $26.71B market cap company. The stock decreased 1.83% or $2.24 during the last trading session, reaching $120.47. About 3.90M shares traded or 81.82% up from the average. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since February 17, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Douglas T. Granat decreased its stake in Kmg Chemicals Inc (KMG) by 22.2% based on its latest 2017Q3 regulatory filing with the SEC. Trigran Investments Inc sold 170,247 shares as the company’s stock rose 52.84% with the market. The hedge fund run by Douglas T. Granat held 596,752 shares of the basic industries company at the end of 2017Q3, valued at $32.75 million, down from 766,999 at the end of the previous reported quarter. Trigran Investments Inc who had been investing in Kmg Chemicals Inc for a number of months, seems to be less bullish one the $950.93 million market cap company. The stock increased 2.72% or $1.64 during the last trading session, reaching $61.86. About 138,384 shares traded. KMG Chemicals, Inc. (NYSE:KMG) has risen 169.63% since February 17, 2017 and is uptrending. It has outperformed by 152.93% the S&P500.

Since August 14, 2017, it had 0 insider purchases, and 30 selling transactions for $34.79 million activity.

Investors sentiment decreased to 0.95 in 2017 Q3. Its down 0.71, from 1.66 in 2017Q2. It fall, as 14 investors sold KMG shares while 47 reduced holdings. 21 funds opened positions while 37 raised stakes. 8.47 million shares or 0.73% less from 8.53 million shares in 2017Q2 were reported. Tower Cap Limited Liability Corporation (Trc) invested 0.01% in KMG Chemicals, Inc. (NYSE:KMG). Acadian Asset Mgmt Ltd Liability accumulated 374,851 shares. Thomson Horstmann Bryant, a Connecticut-based fund reported 25,320 shares. Los Angeles Cap Equity has 0.01% invested in KMG Chemicals, Inc. (NYSE:KMG) for 17,035 shares. 2,826 were accumulated by Victory Cap Mngmt Inc. Envestnet Asset Mngmt Inc has 43 shares. Wellington Llp invested in 0% or 26,607 shares. Barclays Public Ltd Liability Com owns 3,709 shares. California State Teachers Retirement Sys owns 14,669 shares for 0% of their portfolio. 7,100 are held by Pdts Partners Ltd. Alliancebernstein Limited Partnership has 0% invested in KMG Chemicals, Inc. (NYSE:KMG). Rhumbline Advisers reported 10,632 shares stake. Sei Comm invested in 0% or 852 shares. California Pub Employees Retirement Systems reported 50,543 shares. James Inc has invested 0.05% in KMG Chemicals, Inc. (NYSE:KMG).

Among 5 analysts covering KMG Chemicals (NYSE:KMG), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. KMG Chemicals had 9 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of KMG Chemicals, Inc. (NYSE:KMG) earned “Buy” rating by Seaport Global Securities on Friday, December 11. The firm has “Buy” rating given on Wednesday, December 13 by KeyBanc Capital Markets. The stock of KMG Chemicals, Inc. (NYSE:KMG) has “Buy” rating given on Monday, May 1 by Gabelli. On Monday, August 31 the stock rating was downgraded by Zacks to “Hold”. On Wednesday, August 26 the stock rating was upgraded by Global Hunter Securities to “Neutral”. The stock has “Strong-Buy” rating by Zacks on Wednesday, August 12. As per Wednesday, December 14, the company rating was downgraded by Gabelli.

Trigran Investments Inc, which manages about $278.36M and $443.70M US Long portfolio, upped its stake in Ceco Environmental Corp (NASDAQ:CECE) by 550,799 shares to 2.63M shares, valued at $22.29 million in 2017Q3, according to the filing. It also increased its holding in Dolby Laboratories Inc (NYSE:DLB) by 66,247 shares in the quarter, for a total of 178,621 shares, and has risen its stake in Model N Inc (NYSE:MODN).

Analysts await KMG Chemicals, Inc. (NYSE:KMG) to report earnings on March, 12. They expect $0.71 earnings per share, up 24.56% or $0.14 from last year’s $0.57 per share. KMG’s profit will be $10.91 million for 21.78 P/E if the $0.71 EPS becomes a reality. After $0.83 actual earnings per share reported by KMG Chemicals, Inc. for the previous quarter, Wall Street now forecasts -14.46% negative EPS growth.

Temasek Holdings Private Ltd, which manages about $17.17B US Long portfolio, decreased its stake in Ihs Markit Ltd by 3.84 million shares to 17.34 million shares, valued at $764.20 million in 2017Q3, according to the filing.

Since August 28, 2017, it had 0 buys, and 14 selling transactions for $6.68 million activity. Wagner Heidi L sold $16,800 worth of stock or 120 shares. Another trade for 1,651 shares valued at $192,028 was sold by Goff Brian. $707,048 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares were sold by Clancy Paul J. $1.56M worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by O’Neill Julie. Another trade for 2,553 shares valued at $310,521 was made by HANTSON LUDWIG on Tuesday, January 2. $169,696 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Franchini Indrani Lall on Tuesday, February 6.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 24 have Buy rating, 0 Sell and 5 Hold. Therefore 83% are positive. Alexion Pharmaceuticals Inc. had 100 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, September 26 the stock rating was maintained by Leerink Swann with “Outperform”. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Vetr on Wednesday, August 12. As per Tuesday, December 13, the company rating was downgraded by Morgan Stanley. BMO Capital Markets maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Friday, July 21 with “Buy” rating. The firm earned “Buy” rating on Friday, December 11 by Stifel Nicolaus. The rating was initiated by Citigroup with “Neutral” on Thursday, February 25. JP Morgan initiated Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Monday, July 27 with “Overweight” rating. Robert W. Baird maintained the shares of ALXN in report on Friday, June 23 with “Hold” rating. On Friday, October 28 the stock rating was upgraded by Goldman Sachs to “Buy”. The company was maintained on Thursday, February 4 by Barclays Capital.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.20, from 1.37 in 2017Q2. It is negative, as 36 investors sold ALXN shares while 174 reduced holdings. 78 funds opened positions while 167 raised stakes. 206.89 million shares or 0.54% less from 208.01 million shares in 2017Q2 were reported. Inv Of Virginia Ltd Liability Com owns 4,760 shares or 0.16% of their US portfolio. Bnp Paribas Asset Management Holding Sa reported 9,401 shares. Swiss Bancorp accumulated 0.13% or 827,141 shares. Fdx Advsr accumulated 10,614 shares. Toronto Dominion Bancorporation holds 0.04% or 84,717 shares in its portfolio. Keybank Association Oh, Ohio-based fund reported 4,744 shares. Moreover, Jpmorgan Chase & has 0.05% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Lazard Asset Mgmt Lc stated it has 12 shares or 0% of all its holdings. Daiwa Secs Group, Japan-based fund reported 6,582 shares. Da Davidson, Montana-based fund reported 2,156 shares. Cim Inv Mangement reported 0.24% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Massachusetts Fincl Services Communications Ma has invested 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Moreover, Alliancebernstein Lp has 0.05% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Pictet Asset Mngmt Limited has invested 0.45% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Raymond James & reported 0.05% stake.

Leave a Reply

Your email address will not be published. Required fields are marked *